Latest Breaking News On - Feldmanag neoreviews - Page 1 : comparemela.com

Newswire & Press Release / U S FDA Approves Bylvay® for Patients Living with Cholestatic Pruritus Due to Alagille Syndrome - Pharma / BioTech / Nutrition - IPSEN Group

Newswire & Press Release / U S FDA Approves Bylvay® for Patients Living with Cholestatic Pruritus Due to Alagille Syndrome - Pharma / BioTech / Nutrition - IPSEN Group
newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesFrance generalAsia pacificHoward mayerNadia ovchinskyRoberta smithAmy wolfNicolas boglerBoulogne billancourtIoana piscociuFeldmanag neoreviewsAnna gibbinsDivision of gastroenterologyDrug administrationHead of corporate brand strategy communications

U S FDA approves Bylvay® for patients living with cholestatic pruritus due to Alagille syndrome

Approval heralds the second rare cholestatic liver disease indication for Bylvay in the U.S. after progressive familial intrahepatic cholestasis related pruritus in 2021 Immediate U.S. commercial. | June 13, 2023

France generalUnited statesUnited kingdomRoberta smithHoward mayerAnna gibbinsAmy wolfNadia ovchinskyAsia pacificIpsen euronextNicolas boglerIoana piscociuFeldmanag neoreviewsGlobal head of franchise communicationsDrug administrationHuman services

Ipsen Pharma: U S FDA approves Bylvay® for patients living with cholestatic pruritus due to Alagille syndrome

Ipsen Pharma: U S FDA approves Bylvay® for patients living with cholestatic pruritus due to Alagille syndrome
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalUnited statesNicolas boglerAmy wolfIoana piscociuIpsen euronextRoberta smithNadia ovchinskyFeldmanag neoreviewsHoward mayerAsia pacificAnna gibbinsCommittee for medicinal products humanHead of corporate brand strategy communicationsDrug administration

U S FDA approves Bylvay® for patients living with cholestatic pruritus due to Alagille syndrome

U S FDA approves Bylvay® for patients living with cholestatic pruritus due to Alagille syndrome
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalUnited kingdomIoana piscociuHoward mayerFeldmanag neoreviewsAmy wolfAnna gibbinsRoberta smithNicolas boglerAsia pacificIpsen euronextNadia ovchinskyDevelopment for ipsenAmerican association for study of liver diseasesGlobal head of franchise communications

Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio

Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesUnited kingdomIpsen pharmaIoana piscociusenior managerglobalBakera clinDavid loewSpraula orphanetAmy wolfIpsen euronextFeldmanag neoreviewsCraig marksviceIpsen contactsinvestorsHopkins pj pediatrSchatzb hepatolAldriandj clin